Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial

Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial

AbstractObjective This study aims to assess the efficacy and safety of combining the 308-nm Excimer lamp with Tacrolimus 0.1% ointment, compared to Tacrolimus 0.1% ointment monotherapy, for treating pediatric vitiligo involving less than 10% of the body surface area.Methods Fifty pediatric patients...

Full description

Bibliographic Details
Main Authors: Diala Alshiyab, Saleh A. Ba-shammakh, Abdulqudos Al-Fakih, Osama Tashman, Danyah Sarakbi, Firas Al-qarqaz, Jihan Muhaidat, Ausama Atwan, Michael J. Cork
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Excimer light
pediatric
treatment
vitiligo
The study is registered at clinicaltrials.gov under the identifier NCT06035614
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2023.2296851

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2023.2296851

Similar Items